Cure My Disease

Don't miss your cure!

 Log in / Sign up

Home chemo shot study could free myeloma patients from hospital trips

NCT ID NCT04268199

Recruiting now Symptom relief Sponsor: AHS Cancer Control Alberta Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether people with multiple myeloma can safely give themselves a standard chemotherapy drug (bortezomib) at home, instead of going to a clinic. About 100 stable patients who have already had at least four injections in a hospital will be taught to self-inject. The goal is to see if home administration is safe, practical, and improves quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
bortezomib (Velcade) injection
What this could lead to
If successful, this could allow myeloma patients to receive chemotherapy at home instead of traveling to a clinic, making treatment more convenient and less disruptive.
What could go wrong
This is a small, early-phase study (100 people) focused on feasibility, not on curing the disease. Self-injection carries risks of improper dosing or infection, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYELOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

plasma cell myeloma plasma cell neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MYELOMA MYELOMA MULTIPLE

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Arthur J.E. Child Comprehensive Cancer Centre

    RECRUITING

    Calgary, Alberta, T2N 5G2, Canada

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Cross Cancer Institute

    RECRUITING

    Edmonton, Alberta, T6G 1Z2, Canada

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.